European Union - English - EMA (European Medicines Agency)

les laboratoires servier - pixantrone dimaleate - lymphoma, non-hodgkin - antineoplastic agents - pixuvri is indicated as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-hodgkin b-cell lymphomas (nhl). the benefit of pixantrone treatment has not been established in patients when used as fifth-line or greater chemotherapy in patients who are refractory to last therapy.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

servier laboratories ltd - pixantrone dimaleate - powder for solution for infusion - 29mg